Skip to main content

Trajectories of pain and depressive symptoms among people living with low back pain during the COVID-19 pandemic: a 24-month longitudinal study

Publication ,  Journal Article
Angarita-Fonseca, A; Roy, M; Lacasse, A; Léonard, G; Rainville, P; Marin, MF; Tufa, I; Gentile, EL; Pagé, MG; Roy, JS; Alarie, HM; Meloto, CB ...
Published in: Pain Reports
May 31, 2024

Introduction: We explored trajectories of pain intensity and depressive symptoms over the first 24 months of the pandemic in people with low back pain. Methods: This longitudinal study was conducted alongside the Quebec Low Back Pain Study. Starting in April 2020 and every 3 months until July 2022, 291 participants completed an online survey. Group-based trajectory modeling was used to identify patterns of pain intensity and depressive symptoms. Onset outbreak characteristics were then put in relation with trajectory groups using multivariate logistic regression. Results: The analysis revealed 5 trajectories of pain intensity and depressive symptoms, respectively. The pain trajectories were stable mild (n 5 17, 5.8%); stable moderate (n 5 103, 35.4%); stable severe (n 5 81, 27.8%); U-shape (n 5 24, 8.3%), and inverted U-shape (n 5 66, 22.7%). The trajectories of depressive symptoms were stable none (n 5 58, 19.9%); stable very mild (n 5 61, 21.0%); stable mild (n 5 85, 29.2%); stable moderate (n 5 59, 21.7%); and severe slightly improving (n 5 24, 8.3%). Pre-COVID everyday/nearly everyday pain, average pain intensity, and widespread bodily pain were predictive of pain trajectory groups. Higher pre-COVID depression, acute stress disorder, and lockdown measures-related stress were associated with moderate/severe depressive trajectories. Discussion: Our findings indicated relative stability of pain and depressive symptoms among participants during the COVID-19 pandemic but also highlighted subgroups of people who experienced temporary deterioration or improvement over the first months of the pandemic that then reverted back to baseline levels. Modifiable risk factors were identified before the onset of the pandemic, which could give preventive measures in targeted populations.

Duke Scholars

Published In

Pain Reports

DOI

EISSN

2471-2531

Publication Date

May 31, 2024

Volume

9

Issue

4

Start / End Page

e1165

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 3209 Neurosciences
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Angarita-Fonseca, A., Roy, M., Lacasse, A., Léonard, G., Rainville, P., Marin, M. F., … Wideman, T. (2024). Trajectories of pain and depressive symptoms among people living with low back pain during the COVID-19 pandemic: a 24-month longitudinal study. Pain Reports, 9(4), e1165. https://doi.org/10.1097/PR9.0000000000001165
Angarita-Fonseca, A., M. Roy, A. Lacasse, G. Léonard, P. Rainville, M. F. Marin, I. Tufa, et al. “Trajectories of pain and depressive symptoms among people living with low back pain during the COVID-19 pandemic: a 24-month longitudinal study.” Pain Reports 9, no. 4 (May 31, 2024): e1165. https://doi.org/10.1097/PR9.0000000000001165.
Angarita-Fonseca A, Roy M, Lacasse A, Léonard G, Rainville P, Marin MF, et al. Trajectories of pain and depressive symptoms among people living with low back pain during the COVID-19 pandemic: a 24-month longitudinal study. Pain Reports. 2024 May 31;9(4):e1165.
Angarita-Fonseca, A., et al. “Trajectories of pain and depressive symptoms among people living with low back pain during the COVID-19 pandemic: a 24-month longitudinal study.” Pain Reports, vol. 9, no. 4, May 2024, p. e1165. Scopus, doi:10.1097/PR9.0000000000001165.
Angarita-Fonseca A, Roy M, Lacasse A, Léonard G, Rainville P, Marin MF, Tufa I, Gentile EL, Pagé MG, Roy JS, Alarie HM, Meloto CB, Leclair E, Montagna F, Goulet J, Stone LS, Dupuis L, Diatchenko L, Choinière M, da Silva R, Descarreaux M, Fortin M, Langevin P, Ware M, Tétreault P, Hovey R, Deslauriers S, Grégoire S, Wideman T. Trajectories of pain and depressive symptoms among people living with low back pain during the COVID-19 pandemic: a 24-month longitudinal study. Pain Reports. 2024 May 31;9(4):e1165.

Published In

Pain Reports

DOI

EISSN

2471-2531

Publication Date

May 31, 2024

Volume

9

Issue

4

Start / End Page

e1165

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 3209 Neurosciences
  • 3202 Clinical sciences